Midterm Safety and Performance of a Leadless Cardiac Pacemaker: 3-Year Follow-up to the LEADLESS Trial (Nanostim Safety and Performance Trial for a Leadless Cardiac Pacemaker System).

Tjong, Fleur V Y

Midterm Safety and Performance of a Leadless Cardiac Pacemaker: 3-Year Follow-up to the LEADLESS Trial (Nanostim Safety and Performance Trial for a Leadless Cardiac Pacemaker System). [electronic resource] - Circulation 02 2018 - 633-635 p. digital

Publication Type: Letter; Research Support, Non-U.S. Gov't

1524-4539

10.1161/CIRCULATIONAHA.117.030106 doi


Aged
Aged, 80 and over
Arrhythmias, Cardiac--diagnosis
Cardiac Pacing, Artificial--adverse effects
Clinical Trials as Topic
Equipment Design
Female
Humans
Male
Pacemaker, Artificial--adverse effects
Retrospective Studies
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome